Andreas Wirger
Impact in
-
- Renin-Angiotensin System Studies
- Cardiac Fibrosis and Remodeling
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac electrophysiology and arrhythmias
Papers in
-
- Cell death mechanisms and regulation 3
- Ubiquitin and proteasome pathways 2
- Oncology 4
- Cancer-related Molecular Pathways 2
- Cancer Treatment and Pharmacology 1
- Co-authors
- Juergen Holtz (1 shared paper)H. Drexler (1 shared paper)U. N. Riede (1 shared paper)Bernhard Schieffer (1 shared paper)S. Seitz (1 shared paper)Frank Perabo (10 shared papers)Doris Schmidt (9 shared papers)Stefan C. Mueller (4 shared papers)
- Journals
- British Journal of Cancer (1 paper)International Journal of Cancer (1 paper)Circulation (1 paper)Urologic Oncology Seminars and Original Investigations (1 paper)European Journal of Cancer Supplements (1 paper)
- Partner nations
- GermanyUnited States
In The Last Decade
Andreas Wirger
11 papers receiving 556 citations
Peers
Comparison fields: 5 of 72
- Cardiology and Cardiovascular Medicine 312
- Drug Discovery 1
- Endocrinology, Diabetes and Metabolism 72
- Oncology 92
- Molecular Biology 202
Countries citing papers authored by Andreas Wirger
This map shows the geographic impact of Andreas Wirger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Wirger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Wirger more than expected).
Fields of papers citing papers by Andreas Wirger
This network shows the impact of papers produced by Andreas Wirger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Wirger. The network helps show where Andreas Wirger may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Wirger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 352 | |
| 2 | Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer. | 2006 | 36 |
| 3 | Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo. | 2005 | 32 |
| 4 | 2005 | 30 | |
| 5 | 2001 | 29 | |
| 6 | Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2. | 2004 | 27 |
| 7 | Superantigen-activated mononuclear cells induce apoptosis in transitional cell carcinoma. | 2005 | 22 |
| 8 | 2001 | 20 | |
| 9 | Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignancies. | 2001 | 18 |
| 10 | Carboxyamido-triazole (CAI) reverses the balance between proliferation and apoptosis in a rat bladder cancer model. | 2005 | 6 |
| 11 | 2003 | 1 |
About Andreas Wirger
Andreas Wirger is a scholar working on Molecular Biology, Oncology, Immunology, Surgery and Pathology and Forensic Medicine, having authored 11 papers that have together received 573 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Cell death mechanisms and regulation (3 papers), Cancer-related Molecular Pathways (2 papers), Cancer Research and Treatments (2 papers), Cancer Mechanisms and Therapy (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Ubiquitin and proteasome pathways (2 papers) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (312 citations), Drug Discovery (1 citation), Endocrinology, Diabetes and Metabolism (72 citations), Oncology (92 citations) and Molecular Biology (202 citations). Andreas Wirger has collaborated with scholars based in Germany and United States. Frequent co-authors include Juergen Holtz, H. Drexler, U. N. Riede, Bernhard Schieffer, S. Seitz, Frank Perabo, Doris Schmidt, Stefan C. Mueller, Stefan C. Müller and Alexander von Ruecker. Their work appears in journals such as British Journal of Cancer, International Journal of Cancer, Circulation, Urologic Oncology Seminars and Original Investigations and European Journal of Cancer Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.